LIC Healthcare Growth Direct Plan
SIP amount
Min. ₹200
Lumpsum amount
Min. ₹5,000

LIC Healthcare Growth Direct Plan

NAV
₹30.6559
-0.34%
(30 May)
AUM
84 Cr
TER
1.22%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+19.5%
+9.9%
+6.6%
-0.5%
-0.7%
3Y
+20.4%
+35.5%
+35.6%
+38.8%
+37.2%
5Y
+18.5%
+34.0%
+38.9%
+33.4%
+34.1%
ALL
+19.6%
+18.4%
+13.3%
+17.5%
+12.2%
VOL
16.1%
16.4%
21.3%
19.9%
20.4%
TER
1.2%
0.6%
1.0%
0.9%
0.8%
AUM
₹84 Cr
₹6,485 Cr
₹2,392 Cr
₹1,281 Cr
₹5,035 Cr
INFO
1.22
1.12
0.62
0.88
0.60
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
LIC Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
Sun Pharmaceuticals Industries Ltd
10.1%
Piramal Pharma Ltd
5.3%
Torrent Pharmaceuticals Ltd
5.2%
Cipla Ltd
5.0%
Aurobindo Pharma Ltd
4.6%
Divi's Laboratories Ltd
4.5%
Treps
4.3%
Artemis Medicare Services Ltd Ordinary Shares
4.1%
Alkem Laboratories Ltd
3.8%
Navin Fluorine International Ltd
3.6%
Top industry exposure
Healthcare
89.3%
Basic Materials
6.5%
Other information
Minimum SIP
₹200
Minimum lumpsum
₹5,000
Additional lumpsum
₹500
Portfolio turnover
41%
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
Fund manager(s)
Karan Doshi

FAQs